Caxton Corp is based out of Princeton. Their last reported 13F filing for Q1 2025 included $5,080,779 in managed 13F securities
and a top 10 holdings concentration of 99.52%. Caxton Corp's largest holding is Rezolute Inc with shares held of 1,318,967. Whalewisdom has at least 55 13F filings, 17 13D filings, and 49 13G filings
Confidential Treatment - This manager has
obtained confidential treatment for one or more investments in
the most recent 13F filing.
2025-03-31
Top Buys (13F)
| Name | % Change |
|---|---|
| GLD SPDR Gold Shares ETF | 5.66% |
2025-03-31
Top Sells (13F)
| Name | % Change |
|---|---|
| XERS Xeris Biopharma Hold | 41.06% |
| SPY SPDR S&P 500 ETF TRU | 9.94% |
| GLYC GlycoMimetics Inc | 0.31% |
2025-03-31
13F Holdings Summary
| Name | $ Change |
|---|---|
| RZLT Rezolute Inc | 75.28% |
| GLD SPDR Gold Shares ETF | 7.36% |
| BRK.B Berkshire Hathaway I | 4.9% |
| MNMD Mind Medicine Inc | 3.92% |
| BCAX Bicara Therapeutics | 2.81% |
Confidential Treatment - Holdings omitted in latest filing.
2025-03-31
13F Activity
| Market Value | $5.08m, Prior: $16.6m |
| Inflows (Outflows) as % of Total MV | (-57.5624)% |
| New Purchases | 0 stocks |
| Added To | 1 stocks |
| Sold out of | 3 stocks |
| Reduced holdings in | 1 stocks |
| Top 10 Holdings % | 99.52% |
| Turnover %[1] | 20% |
| Turnover Alt %[2] | 0.73% |
| Time Held Top 20 | 4.6667 quarters |
| Time Held Top 10 | 4.2 quarters |
| Time Held All | 4.67 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2025-03-31
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2025-03-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2025-03-31